Sim Man 3G returns
Full programme and session descriptions
SEE PAGE 3
Congress floorplan and exhibitors list SEE PAGE 12
BNF
SEE PAGE 8
24/7
@CPCongress
The Clinical Pharmacy Congress Network
www.pharmacycongress.co.uk/facebook
Clinical. Production. Procurement. Optimisation. Whatever your role in pharmacy, we’ve got it covered! The clinical skills of pharmacy professionals are being discussed everywhere. Whatever role you have, bringing increased knowledge of medicines and the understanding of how to achieve better financial and clinical outcomes from those medicines if becoming more important. That is why The Clinical Pharmacy Congress this year expects over 2,300 pharmacy professionals to attend across the two days. It is not just the 76 hours of accredited education on offer that is important, Congress provides an unequalled opportunity for networking with the thought-leaders in the profession.
Clinical pharmacy – a future view Join us at ExCeL London, on April 22-23 and don’t miss the keynote address from Dr Bruce Warner, Deputy Chief Pharmacist at NHS England. See the winners of the ‘Clinical Pharmacy Congress Awards’ to gain inspiration from those leading the implementation of innovative new services. And, hear about both new and advanced roles within clinical pharmacy practice. Don’t miss sessions discussing the emerging new roles for clinical pharmacists in general practice, care homes, emergency care and embedded pharmacists in ward MDTs. Visit the Congress Education Hub where visitors can interact with representatives from leading universities – perhaps you can find the advanced course to give your expertise and career a boost?
More conference work streams Congress has maintained seven successful work streams from last year including Keynote, Leadership, Clinical, Medicines Optimisation, Innovation & Technology and the Strategy and Policy Forum. This conference programme is delivered by a world-class faculty of speakers, led by Dr Bruce Warner who is
PRE CONGRESS NEWSPAPER 2016
CSUs: Autonomy brings opportunity and risk Significant opportunities - but with new risks and much keener competition - will become the watchword for England’s Commissioning Support Units (CSU), as they progress along their individual journeys of autonomy, North East Commissioning Support Unit managing director Stephen Childs has said. And, spelling out these challenges, he says: “Commissioning customers and their stakeholders will have to strive to balance the enormous challenge of delivering high quality care within an increasingly pressured budget today - whilst designing a more efficient, integrated system that better serves the needs of patients tomorrow.” Since their establishment following the NHS reorganisation of 2012, England’s CSUs – organisations brought to life within the NHS to offer support services to NHS commissioners – have been expected to become autonomous bodies.
ably supported by a variety of specialists from the Department of Health, NHS England and the GPhC, amongst others. This year we have added the new Clinical Pharmaceutics and Technical Services stream, which has been programmed in conjunction with the Technical Specialist Education and Training Group (TSET) and the Radio Pharmacy Group with content for those working in quality assurance / quality control, radiopharmacy, aseptic services, production and manufacturing as well as procurement services and clinical trials. This year’s Congress delivers a unique range of educational sessions, from the medicines legislation and pharmacy regulation to advanced clinical knowledge and skills. Don’t miss some very topical issues such as antibiotic stewardship, medicines use in learning disabilities, dementia care, automation and technology. There are some intriguing titles: • • • •
Cancer medicines: Making the unaffordable affordable through medicines optimisation Health and justice pharmacy practice Steps to pharmacy heaven A career in mental health pharmacy
If you don’t know what these are about you might just have to go and participate! CONT. P3
And, by the end of this year – some three years after the original transition to autonomy deadline was first mooted - CSUs will be expected to apply to NHS England for validation or assurance that they are ready to grasp this nettle. Autonomy from the NHS will rapidly thrust CSUs into an environment where NHS commissioners, and other customers, are free to adopt – or abandon –the CSU’s support service offer. Therefore, having a quality service offer that lifts the capacity and capability of the commissioning system will be vital to the autonomous CSU’s ongoing financial success. “CSUs have no guarantee of winning income if they are not the first choice of customers,” NHS England has warned in a Board report from 2014.1
Benefits of autonomy As NHS England hosted organisations, CSUs are legally obliged to observe rules common to the public sector, such as those relating to procurement, formal financial control, management of risk, and nationally set staffing policies. But, in an increasingly competitive environment, this regime significantly constrains CSUs’ ability to respond to customers’ needs in an increasingly competitive environment. CONT. P6
Register NOW at www.pharmacycongress.co.uk /newspaper Conference partners:
Education partners:
UK Renal Pharmacy Group